Pharmaceutical - Mergers & Acquisitions


Current filters:

Mergers & Acquisitions

Popular Filters

651 to 656 of 656 results

Menarini strongly denies it is looking to sell or list on stock exchange


Family-owned Italian drugmaker Menarini categorically denies that it has given any kind of mandate to…

FinancialMenariniMergers & AcquisitionsPharmaceutical

Alkermes shareholders vote in favor of merger with Elan Drug Technology


Shareholders of USA-based Alkermes (Nasdaq; ALKS) have voted to approve the previously-announced $960…

AlkermesElanElan Drug TechnologiesMergers & AcquisitionsPharmaceutical

Valeant out-bids Paladin with C$76 million cash bid for Afexa


Acquisitive Canadian drugmaker Valeant Pharmaceuticals International (TSX: VRX) says that it has entered…

Afexa Life SciencesMergers & AcquisitionsPaladin LabsPharmaceuticalValeant Pharmaceuticals

Baxter pays $380 million to acquire drug delivery firm Baxa


USA-based Baxter International (NYSE: BAX) has entered into a definitive agreement to acquire Baxa Corp,…

Baxa CorpBaxter InternationalMergers & AcquisitionsPharmaceutical

Speculation Takeda is looking to buy India’s Cipla or Lupin; Sanofi acquires OTC firm


Japan’s largest drugmaker Takeda Pharmaceuticals (TYO: 4502) is in talks with two of India’s…

Asia-PacificCiplaLupinMergers & AcquisitionsPharmaceuticalSanofiTakeda PharmaceuticalsUniversal Medicare

651 to 656 of 656 results

Back to top